首页> 外文OA文献 >Bone Mineral Density (BMD) Reductions After Tenofovir Disoproxil Fumarate (TDF) Initiation Are Not Associated With Changes in Phosphaturia: A Secondary Analysis of ACTG A5224s

【2h】

Bone Mineral Density (BMD) Reductions After Tenofovir Disoproxil Fumarate (TDF) Initiation Are Not Associated With Changes in Phosphaturia: A Secondary Analysis of ACTG A5224s

机译：骨矿物密度（BMD）减少尖端毒性富马酸核酸富马酸核苷酸（TDF）引发与磷酸尿的变化无关：ACTG A5224S的二次分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Samir Gupta; Eunice Yeh; Douglas Kitch; Todd Brown; Charles Venuto; Gene Morse; Belinda Ha; Kathy Melbourne; Grace McComsey;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s [J] . Gupta Samir K., Yeh Eunice, Kitch Douglas W., The Journal of Antimicrobial Chemotherapy . 2017,第7期

机译：胞型毒性富马酸莫酸莫酸莫酸莫酸骨粉骨矿物密度减少及磷酸性磷的变化：ACTG A5224S的二级分析
2. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. [J] . McComsey GA, Kitch D, Daar ES, The Journal of Infectious Diseases . 2011,第12期

机译：初次接受抗逆转录病毒治疗的人的骨矿物质密度和骨折随机接受阿巴卡韦-拉米夫定或替诺福韦二吡呋酯富马酸-恩曲他滨联合依非韦伦或阿扎那韦-利托那韦：艾滋病临床试验组A5224s，是ACTG A5202的一项子研究。
3. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 [J] . Grace A. McComsey, Douglas Kitch, Eric S. Daar, Journal of Infectious Diseases . 2011,第12期

机译：抗逆转录病毒天真患者的骨矿物质密度和骨折，随机接受阿巴卡韦-拉米夫定或替诺福韦地替莫韦酯富马酸酯-依米他滨与依非韦伦或阿扎那韦-利托那韦的联合治疗：AIDS临床试验组A5224s，是ACTG A5202的一项子研究
4. Automated measurement of bone-mineral-density (BMD) values of vertebral bones based on X-ray torso CT images [C] . X. Zhou, T. Hayashi, H. Chen, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2009

机译：基于X射线躯干CT图像的椎体密度（BMD）值的自动测量
5. Effects of Resistance Exercise Compared to Weight-Bearing Aerobic Exercise on Bone Mineral Density, Fall Risk, and Quality of Life for Postmenopausal Women with Low Bone Mass: A Meta-Analysis [D] . Kwon, Diane. 2020

机译：抗性运动对骨密度，下降风险和低骨质妇女的骨密度，落下风险和生活质量相比的影响：META分析
6. Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s [O] . Samir K. Gupta, Eunice Yeh, Douglas W. Kitch, -1

机译：替诺福韦富马酸替诺福韦酯加重和血尿改变后骨矿物质密度降低：ACTG A5224s的二级分析
7. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 [O] . McComsey, Grace A., Kitch, Douglas, Daar, Eric S., 2011

机译：抗逆转录病毒天真患者的骨矿物质密度和骨折，随机接受阿巴卡韦-拉米夫定或替诺福韦地替莫韦酯富马酸酯-依米他滨与依非韦伦或阿扎那韦-利托那韦的联合治疗：AIDS临床试验组A5224s，是ACTG A5202的一项子研究

Bone Mineral Density (BMD) Reductions After Tenofovir Disoproxil Fumarate (TDF) Initiation Are Not Associated With Changes in Phosphaturia: A Secondary Analysis of ACTG A5224s

著录项

引文网络

相似文献

相关主题

期刊订阅